by Richard Daverman, PhD
December 3, 2013 -- Hebei Medical University Biomedical Engineering Center (HMUBEC) in-licensed China rights to a pre-clinical cancer treatment from Sareum Holdings plc of Britain. HMUBEC is part of Hebei Medical University Science & Technology General Company (HMUSTGC), which has labs, manufacturing facilities and sales/distribution channels. Since its founding in 1992, HMUSTGC has developed more than 85 therapeutic products and medical devices for the Chinese market. More details....
Stock Symbol: (AIM: SAR)
Help employers find you! Check out all the jobs and post your resume.
